$2.1B Endocyte Deal a Record-Breaker

Posted: Updated:
(Image courtesy of Endocyte) (Image courtesy of Endocyte)
WEST LAFAYETTE -

A veteran of Indiana's life sciences industry says the proposed blockbuster sale of West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is good for the ecosystem in the state. Switzerland-based Novartis AG has signed an agreement to acquire Endocyte for $2.1 billion, which BioCrossroads Project Director Brian Stemme says is "by far" the largest-ever acquisition of an Indiana life sciences company. The deal still faces regulatory and shareholder hurdles.

In an interview with Inside INdiana Business, Stemme said the deal is validation of more than 20 years of support and determination. The company was born in the mid-1990s from biotechnology developed at Purdue University by eventual founder Philip Low and fellow biochemist Christopher Leamon. Low serves as chief science officer and Leamon is vice president of research and development.

"There's been just a lot of people between Dr. Low, Purdue University, the state of Indiana, all the executives and scientists that have been supporting that company over the years, so to see it really be recognized and work with a company that can help get that product to market, it's exciting," Stemme said. "It's a validation that all those folks knew what they were doing, knew what they were talking about, they saw the promise of that technology early and then just kept on grinding."

Stemme says the deal adds to some $8 billion in transactions involving Hoosier life sciences businesses in the last five years, including:

Endocyte is based at Purdue Research Park in West Lafayette, and last month, it was recognized as the first Purdue startup to be valued at $1.5 billion. Purdue President Mitch Daniels says "the sale of Endocyte is a landmark moment, but given the explosion in entrepreneurship and new start-ups at Purdue, I'm sure it's the first of many to come. "We are so deeply proud of our Purdue scientists whose genius is saving lives from cancer, and now has brought great new wealth to Indiana."

Last year, the company acquired a promising prostate cancer therapy in the late stages of development from ABX GmbH in Germany. Endocyte says it expects the acquisition will boost the chances of PSMA-617 going to market. Endocyte went public in 2011, raising $79 million during its initial public offering.

BioCrossroads Project Director Brian Stemme said the deal is validation of more than 20 years of support and determination.
  • Perspectives

    • Richardson is a practice lead with Centric Consulting.

      How to Create Consistent and Positive Customer Experiences with Your Brand

      Everyone knows that keeping the consumer happy is the first priority. The importance of considering the customer’s experience in all areas of engaging with your business, not just customer service is becoming even more clear. I’m seeing an increasing number of my peers in the marketing world take ownership of the customer experience with their brands. As a result, we’re all learning how to borrow and...

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • (image courtesy of The Times of Northwest Indiana)

      U.S. Steel Updates Layoff Notice to State

      Pittsburgh-based U.S. Steel Corp. (NYSE: X) has updated the State of Indiana regarding its previously announced layoffs at the East Chicago Tin Mill. The company says 314, rather than 307, workers will be displaced when the mill is idled this fall. 

    • Red Star announced plans to expand and add 18 jobs.

      Larwill Medical Device Maker to Expand, Add Jobs

      A Whitley County-based medical device maker has announced plans to expand its facility in Larwill which should mean new jobs. Red Star Contract Manufacturing Inc. says it will invest $1.6 million in real estate improvements and additional equipment and will create 18 new jobs by 2022. 

    • Regal Beloit is closing in Valparaiso. (photo courtesy; The Times of Northwest Indiana)

      Valpo Bearings Plant to Close, Eliminating 160+ Jobs

      Wisconsin-based Regal Beloit Corp. and the union representing workers have reached an agreement about the closing of a helicopter bearing factory in Valparaiso. According to our partners at The Times of Northwest Indiana, the decision will cost between 160 to 170 workers their jobs. 

    • (WISH-TV Photo)

      Clif Bar Expands Indy Bakery

      California-based Clif Bar & Co. has completed a $10 million expansion of its commercial bakery in Indianapolis. The company says the project involved a more sustainable redesign of the facility for its employee-owners with a greater focus on energy efficiency.

    • Bob Stutz

      New Role For Salesforce Exec

      After three years on the job, Salesforce Marketing Cloud Chief Executive Officer Bob Stutz is moving into a new role. Stutz, who will remain in Indianapolis, is now executive vice president of strategic partners at Salesforce (NYSE: CRM).  Since arriving in Indianapolis, Stutz has overseen the establishment of the company’s regional headquarters in downtown Indianapolis, which included the Salesforce name being placed atop the state’s tallest building.